SYNDEVRX
Syndevrx is a biotech company that specializes in the development of treatments for cancers sensitive to metabolic hormones. Its drugs focus to treat the tumor directly and improve the underlying metabolic hormone dysfunction.
SYNDEVRX
Industry:
Biotechnology Health Care Medical
Founded:
2007-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.syndevrx.com
Total Employee:
1+
Status:
Active
Contact:
617-401-3110
Total Funding:
14.7 M USD
Technology used in webpage:
Euro Google Google Cloud
Similar Organizations
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Sesen Bio, Inc.
Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
Ensemble Discovery
Ensemble develops Ensemblins to treat diseases by addressing drug targets that are currently inaccessible with small molecule drugs.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Myomo
Myomo develops devices with myoelectric prosthetic technology to restore the mobility of individuals with muscle weakness.
Nano Precision Medical
Nano Precision Medical develops novel miniaturized subdermal implants
Owl biomedical
Owl biomedical develops microchip-based disposable cell sorting technology.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Tandem Diabetes Care
Tandem diabetes care provides products that empower both people with diabetes and those who care for them.
Current Employees Featured
Bradley J Carver Co-founder, President, CEO and Chairman @ Syndevrx
Co-founder, President, CEO and Chairman
2007-02-01
James M. Shanahan Co-Founder and Chief Business Officer @ Syndevrx
Co-Founder and Chief Business Officer
2007-02-01
Founder
Official Site Inspections
http://www.syndevrx.com Semrush global rank: 9.02 M Semrush visits lastest month: 445
- Host name: 175.56.185.35.bc.googleusercontent.com
- IP address: 35.185.56.175
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Syndevrx"
Leadership & Management - SynDevRx, Inc.
At SynDevRx, Jim in responsible for developing the company’s strategic business plans, strategic direction and outreach, operations, IP, and funding. Previously, Jim co-founded JAM …See details»
About Us - SynDevRx, Inc.
The SynDevRx team includes an impressive roster of well-known clinical oncologists, leaders in academic research, professors from premier institutions and experienced drug development …See details»
Syndevrx - Crunchbase Company Profile & Funding
Organization. Syndevrx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Syndevrx is a biotech company that specializes …See details»
Board of Directors - SynDevRx, Inc.
At SynDevRx, Jim in responsible for developing the company’s business plans, strategic direction and outreach, operations, IP, and funding. Previously, Jim co-founded JAM Technologies, a fabless semiconductor company serving the …See details»
SynDevRx Company Profile 2024: Valuation, Funding
SynDevRx General Information Description. Developer of cancer therapies technology designed to treat tumors sensitive to systemic, dysregulated metabolic hormones. The company's therapies focus on treating the tumor directly and …See details»
SynDevRx, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore SynDevRx, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 2 news, and 8 literature, Disease Domain:Endocrinology and ...See details»
SynDevRx CEO and Key Executive Team | Craft.co
SynDevRx's Co-Founder, Chairman of the Board, President and Chief Executive Officer is Bradley Carver. Other executives include Eric Tooker, Director; Neal Salomon, Consulting …See details»
SynDevRx, Inc. - LinkedIn
SynDevRx, Inc. | 104 followers on LinkedIn. ... Cross Border Education Research Team (C-BERT) Higher Education Oxford, OhioSee details»
SynDevRx - Overview, News & Similar companies | ZoomInfo.com
Who is SynDevRx. SynDevRx is a privately held clinical-stage biopharmaceutical company based in Cambridge, Massachusetts. that is leading the research and developme nt of treatments …See details»
Syndevrx, Inc. Company Profile | Cambridge, MA | Competitors ...
Syndevrx, Inc. Website. Get a D&B Hoovers Free Trial. Overview Company Description:? Key Principal: Bradley Carver See more contacts Industry: Scientific Research and Development …See details»
Syndevrx - Contacts, Employees, Board Members, Advisors & Alumni
Syndevrx has 2 current employee profiles, including Co-founder, President, CEO and Chairman Bradley J Carver. Bradley J Carver Co-founder, President, CEO and Chairman James M. …See details»
SynDevRx Company Profile - Office Locations, Competitors ... - Craft
SynDevRx has 1 employees at their 1 location and $1.07 m in total funding,. See insights on SynDevRx including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Syndevrx - Funding, Financials, Valuation & Investors - Crunchbase
Organization. Syndevrx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 5. obfuscated. Total Funding …See details»
Cambridge-Based Biotech SynDevRx Announces Scientific
Mar 28, 2024 SynDevRx, a clinical-stage company located in the biotech hub of Cambridge, MA, is at the forefront of biotechnological innovation, focusing on developing novel therapies that …See details»
Brad Carver - SynDevRx, Inc. | LinkedIn
I have over 30 years of experience as a senior biotech executive (co-founder, President… · Experience: SynDevRx, Inc. · Education: Michigan State University · Location: Cambridge · 500 ...See details»
Clinical Development - SynDevRx, Inc.
SynDevRx is a clinical-stage biotechnology company focused on developing treatments that address a serious and unmet medical need: cancers that are sensitive to metabolic hormones. …See details»
SynDevRx Announces Research Collaboration with ... - Business Wire
Dec 7, 2021 SynDevRx is a privately held clinical-stage biopharmaceutical company based in Cambridge, Mass. that is leading the research and development of treatments that address …See details»
New Phase 1b/2 Clinical Research Study with SynDevRx Drug …
Jun 1, 2022 SynDevRx is a privately held clinical-stage biopharmaceutical company based in Cambridge, Massachusetts. that is leading the research and development of treatments that …See details»
The Science Behind Our Programs - SynDevRx, Inc.
The link between metabolic dysfunction and cancer outcomes is undeniable. SynDevRx is the leader in the emerging metabo-oncology field of drug development, and our first clinical drug …See details»
News - SynDevRx, Inc.
Aug. 31, 2022 – SynDevRx, Inc., a clinical-stage biotechnology company leading the development of treatments for obesity-accelerated cancers, today announced the presentation of new …See details»